Startseite UR

Einträge von Stoeltzing, Oliver auf dem Publikationsserver

Eine Stufe nach oben
Exportieren als
[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Gruppieren nach: Datum | Dokumentenart | Keine Gruppierung
Gehe zu: 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
Anzahl der Einträge: 22.

2012

Moser, Christian, Ruemmele, Petra, Gehmert, Sebastian, Schenk, Hedwig, Kreutz, Marina P, Mycielska, Maria E, Hackl, Christina, Kroemer, Alexander, Schnitzbauer, Andreas A, Stoeltzing, Oliver, Schlitt, Hans J, Geissler, Edward K und Lang, Sven A (2012) STAT5b as Molecular Target in Pancreatic Cancer—Inhibition of Tumor Growth, Angiogenesis, and Metastases. Neoplasia 14 (10), 915-IN12. Volltext nicht vorhanden.

2011

Lang, Sven Arke, Moser, Christian, Schenk, Hedwig, Ruemmele, Petra, Hackl, Christina, Geissler, Edward K., Stoeltzing, Oliver und Schlitt, Hans J. (2011) Abstract 1658: STAT5b is expressed in human pancreatic cancer and serves as a target for anti-neoplastic therapy. Cancer Research 71 (8_Supp), S. 1658. Volltext nicht vorhanden.

Taeger, Johannes, Moser, Christian, Hellerbrand, Claus, Mycielska, Maria E., Glockzin, Gabriel, Schlitt, Hans J., Geissler, Edward K., Stoeltzing, Oliver und Lang, Sven A. (2011) Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer. Molecular Cancer Therapeutics 10 (11), S. 2157-2167. Volltext nicht vorhanden.

2010

Hackl, Christina, Lang, Sven A., Moser, Christian, Mori, Akira, Fichtner-Feigl, Stefan, Hellerbrand, Claus, Dietmeier, Wolfgang, Schlitt, Hans J., Geissler, Edward K. und Stoeltzing, Oliver (2010) Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition. BMC cancer 10, S. 668.

Lang, Sven A., Hackl, Christina, Moser, Christian, Fichtner-Feigl, Stefan, Koehl, Gudrun E., Schlitt, Hans J., Geissler, Edward K. und Stoeltzing, Oliver (2010) Implication of RICTOR in the mTOR inhibitor-mediated induction of insulin-like growth factor-I receptor (IGF-IR) and human epidermal growth factor receptor-2 (Her2) expression in gastrointestinal cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1803 (4), S. 435-442. Volltext nicht vorhanden.

Stoeltzing, Oliver, Loss, Martin, Huber, Elisabeth, Gross, Volker, Eilles, Christoph, Mueller-Brand, Jan und Schlitt, Hans J. (2010) Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor. Langenbeck's Archives of Surgery 395 (2), S. 185-192. Volltext nicht vorhanden.

2009

Hackl, Christina, Mori, Akira, Moser, Christian, Lang, Sven A., Dayoub, Rania , Weiss, Thomas S. , Schlitt, Hans J., Geissler, Edward K., Hellerbrand, Claus und Stoeltzing, Oliver (2009) Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental models. Surgery 147 (5), S. 704-712. Volltext nicht vorhanden.

Amann, Thomas, Mägdefrau, Ulrike, Hartmann, Arndt, Agaimy, Abbas, Marienhagen, Jörg, Weiss, Thomas S. , Stoeltzing, Oliver, Warnecke, Christina, Schölmerich, Jürgen, Oefner, Peter J. , Kreutz, Marina, Bosserhoff, Anja-Katrin und Hellerbrand, Claus (2009) GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. The American journal of pathology 174 (4), S. 1544-1552. Volltext nicht vorhanden.

Lang, Sven A., Moser, Christian, Fichnter-Feigl, Stefan, Schachtschneider, Philipp, Hellerbrand, Claus, Schmitz, Volker, Schlitt, Hans J., Geissler, Edward K. und Stoeltzing, Oliver (2009) Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice #. Hepatology 49 (2), S. 523-532. Volltext nicht vorhanden.

Mori, Akira, Moser, Christian, Lang, Sven A., Hackl, Christina, Gottfried, Eva, Kreutz, Marina, Schlitt, Hans J., Geissler, Edward K. und Stoeltzing, Oliver (2009) Up-Regulation of Krüppel-Like Factor 5 in Pancreatic Cancer Is Promoted by Interleukin-1β Signaling and Hypoxia-Inducible Factor-1α. Molecular Cancer Research 7 (8), S. 1390-1398. Volltext nicht vorhanden.

2008

Lang, Sven Arke, Brecht, Isabel, Moser, Christian, Obed, Aiman, Batt, David, Schlitt, Hans Juergen, Geissler, Edward Kenneth und Stoeltzing, Oliver (2008) Dual inhibition of Raf and VEGFR2 reduces growth and vascularization of hepatocellular carcinoma in an experimental model. Langenbeck's Archives of Surgery 393 (3), S. 333-341. Volltext nicht vorhanden.

Lang, Sven A., Schachtschneider, Philipp, Moser, Christian, Mori, Akira, Hackl, Christina, Gaumann, Andreas, Batt, David, Schlitt, Hans J., Geissler, Edward K. und Stoeltzing, Oliver (2008) Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes. Molecular Cancer Therapeutics 7 (11), S. 3509-3518. Volltext nicht vorhanden.

Moser, Christian, Lang, Sven A, Mori, Akira, Hellerbrand, Claus, Schlitt, Hans J, Geissler, Edward K, Fogler, William E und Stoeltzing, Oliver (2008) ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo. BMC Cancer 8 (1). Volltext nicht vorhanden.

Moser, Christian, Schachtschneider, Philipp, Lang, Sven A., Gaumann, Andreas, Mori, Akira, Zimmermann, Johann, Schlitt, Hans J., Geissler, Edward K. und Stoeltzing, Oliver (2008) Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis. European Journal of Cancer 44 (11), S. 1577-1586. Volltext nicht vorhanden.

2007

Moser, Christian, Lang, Sven A., Kainz, Silvia, Gaumann, Andreas, Fichtner-Feigl, Stefan, Koehl, Gudrun E., Schlitt, Hans J., Geissler, Edward K. und Stoeltzing, Oliver (2007) Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo. Molecular Cancer Therapeutics 6 (11), S. 2868-2878. Volltext nicht vorhanden.

Lang, Sven A., Klein, Dagmar, Moser, Christian, Gaumann, Andreas, Glockzin, Gabriel, Dahlke, Marc H., Dietmaier, Wolfgang, Bolder, Ulrich, Schlitt, Hans J., Geissler, Edward K. und Stoeltzing, Oliver (2007) Inhibition of heat shock protein 90 impairs epidermal growth factor–mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Molecular Cancer Therapeutics 6 (3), S. 1123-1132. Volltext nicht vorhanden.

Lang, Sven A., Gaumann, Andreas, Koehl, Gudrun E., Seidel, Ulrike, Bataille, Frauke, Klein, Dagmar, Ellis, Lee M., Bolder, Ulrich, Hofstaedter, Ferdinand, Schlitt, Hans‐Jürgen, Geissler, Edward K. und Stoeltzing, Oliver (2007) Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. International Journal of Cancer 120 (8), S. 1803-1810. Volltext nicht vorhanden.

Stoeltzing, Oliver, Liu, Wenbiao, Fan, Fan, Wagner, Christine, Stengel, Kathrin, Somcio, Ray J., Reinmuth, Niels, Parikh, Alexander A., Hicklin, Daniel J. und Ellis, Lee M. (2007) Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system. Cancer Letters 258 (2), S. 291-300. Volltext nicht vorhanden.

Jäger, Mark D., Liu, Jian Y., Timrott, Kai F., Popp, Felix C., Stoeltzing, Oliver, Lang, Sven A., Piso, Pompiliu, Geissler, Edward K., Schlitt, Hans J. und Dahlke, Marc H. (2007) Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats. Experimental Hematology 35 (1), S. 164-170. Volltext nicht vorhanden.

Lang, Sven A., Moser, Christian, Gaumann, Andreas, Klein, Dagmar, Glockzin, Gabriel, Popp, Felix C., Dahlke, Marc H., Piso, Pompiliu, Schlitt, Hans J., Geissler, Edward K. und Stoeltzing, Oliver (2007) Targeting Heat Shock Protein 90 in Pancreatic Cancer Impairs Insulin-like Growth Factor-I Receptor Signaling, Disrupts an Interleukin-6/Signal-Transducer and Activator of Transcription 3/Hypoxia-Inducible Factor-1α Autocrine Loop, and Reduces Orthotopic Tumor Growth. Clinical Cancer Research 13 (21), S. 6459-6468. Volltext nicht vorhanden.

Moser, Christian, Lang, Sven A. und Stoeltzing, Oliver (2007) The Direct Effects of Anti–Vascular Endothelial Growth Factor Therapy on Tumor Cells. Clinical Colorectal Cancer 6 (8), S. 564-571. Volltext nicht vorhanden.

2006

Popp, Felix C., Slowik, Przemyslaw, Eggenhofer, Elke, Renner, Phillip, Lang, Sven A., Stoeltzing, Oliver, Geissler, Edward K., Piso, Pompiliu, Schlitt, Hans J. und Dahlke, Marc H. (2006) No Contribution of Multipotent Mesenchymal Stromal Cells to Liver Regeneration in a Rat Model of Prolonged Hepatic Injury. Stem Cells 25 (3), S. 639-645. Volltext nicht vorhanden.

Diese Liste wurde erzeugt am Sat Dec 21 18:46:55 2024 CET.
  1. Universität

Universitätsbibliothek

Publikationsserver

Kontakt:

Publizieren: oa@ur.de
0941 943 -4239 oder -69394

Dissertationen: dissertationen@ur.de
0941 943 -3904

Forschungsdaten: datahub@ur.de
0941 943 -5707

Ansprechpartner